Innovating Works

TIRME

Activa
RxmiRcanceR: Tumor suppressive microRNAs for cancer therapy TIRME participó en un H2020: ERC-2017-ADG The challenge for cancer therapy involves hampering the mechanisms by which the normal gene expression machinery is taken over to allow the...
2018-08-24 - 2024-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.